The market for neurodegenerative diseases is projected to grow at a CAGR of 7% over the course of the forecast period, from US$ 43.7 Bn in 2021 to US$ 92 Bn by 2032. Due to the rising prevalence of neurological diseases, an ageing population, and rising treatment demand for Alzheimer's and Parkinson's disease, the market for neurodegenerative diseases is anticipated to exhibit promising growth prospects during the period of fore casting.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
